melatonin has been researched along with icg 001 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkinson, BN; Bayle, ED; Fish, PV; Steadman, D; Svensson, F; Vincent, JP; Whiting, P; Willis, NJ; Woodward, HL | 1 |
| Jeong, JK; Park, SY | 1 |
2 other study(ies) available for melatonin and icg 001
| Article | Year |
|---|---|
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.
Topics: Binding Sites; Catalytic Domain; Cell Nucleus; Cytoplasm; Enzyme Inhibitors; Esterases; Humans; Molecular Dynamics Simulation; Small Molecule Libraries; Wnt Signaling Pathway | 2021 |
HIF-1α-induced β-catenin activation prevents prion-mediated neurotoxicity.
Topics: Apoptosis; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Cell Hypoxia; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Melatonin; Neurons; Peptide Fragments; Prion Diseases; Prions; Pyrimidinones; Up-Regulation; Wnt Signaling Pathway | 2013 |